Skip to main content

Biotech

A Gene-Editing Therapy Cut Cholesterol Levels by Half
Crispr For All

A Gene-Editing Therapy Cut Cholesterol Levels by Half

An experimental gene-editing therapy developed by Crispr Therapeutics is showing promise for treating heart disease.